This company listing is no longer active
Orchid Ventures Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Información clave
-6.9%
Tasa de crecimiento de los beneficios
51.5%
Tasa de crecimiento del BPA
| Crecimiento de la industria Pharmaceuticals | 23.1% |
| Tasa de crecimiento de los ingresos | -2.0% |
| Rentabilidad financiera | n/a |
| Margen neto | -236.4% |
| Última actualización de beneficios | 31 Mar 2022 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Orchid Ventures. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 22 | 1 | -3 | 4 | 0 |
| 31 Dec 21 | 2 | -4 | 4 | 0 |
| 30 Sep 21 | 2 | -3 | 4 | 0 |
| 30 Jun 21 | 4 | -3 | 4 | 0 |
| 31 Mar 21 | 3 | -3 | 3 | 0 |
| 31 Dec 20 | 4 | -2 | 3 | 0 |
| 30 Sep 20 | 3 | -4 | 4 | 0 |
| 30 Jun 20 | 1 | -7 | 5 | 0 |
| 29 Feb 20 | 4 | -10 | 8 | 0 |
| 30 Nov 19 | 5 | -11 | 9 | 0 |
| 31 Aug 19 | 5 | -9 | 8 | 0 |
| 31 May 19 | 6 | -7 | 7 | 0 |
| 28 Feb 19 | 4 | -2 | 4 | 0 |
| 30 Nov 18 | 3 | -2 | 4 | 0 |
| 31 Aug 18 | 3 | -1 | 3 | 0 |
| 31 May 18 | 2 | -2 | 3 | 0 |
Ingresos de calidad: ORCD is currently unprofitable.
Margen de beneficios creciente: ORCD is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: ORCD is unprofitable, and losses have increased over the past 5 years at a rate of 6.9% per year.
Acelerando crecimiento: Unable to compare ORCD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: ORCD is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (17.8%).
Rentabilidad financiera
Alta ROE: ORCD's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.